ProfileGDS4718 / 218465_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 91% 81% 92% 93% 96% 93% 91% 91% 92% 94% 90% 93% 93% 93% 93% 93% 92% 94% 83% 92% 92% 93% 93% 93% 93% 93% 91% 90% 96% 93% 95% 91% 93% 93% 92% 94% 91% 91% 80% 91% 94% 89% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.7820893
GSM549102patient 115, normal, homogenized [OPG study]9.3911791
GSM549104patient 119, normal, homogenized [OPG study]8.0416881
GSM549108patient 138, normal, homogenized [OPG study]9.494492
GSM549119patient 077, normal, homogenized [OPG study]9.9099193
GSM549133patient 032, cancer, homogenized [OPG study]10.495596
GSM549139patient 042, cancer, homogenized [OPG study]9.7769493
GSM549099patient 107, normal, homogenized [OPG study]9.4201991
GSM549109patient 139, normal, homogenized [OPG study]9.459191
GSM549110patient 046, normal, homogenized [OPG study]9.7167492
GSM549114patient 063, normal, homogenized [OPG study]10.064494
GSM549122patient 082, normal, homogenized [OPG study]9.2654390
GSM549134patient 033, cancer, homogenized [OPG study]9.681393
GSM549136patient 036, cancer, homogenized [OPG study]9.8769193
GSM549140patient 044, cancer, homogenized [OPG study]9.8424993
GSM549111patient 047, normal, homogenized [OPG study]9.986493
GSM549113patient 057, normal, homogenized [OPG study]10.006293
GSM549132patient 031, cancer, homogenized [OPG study]9.4683292
GSM549137patient 038, cancer, homogenized [OPG study]9.7821994
GSM549142patient 047, cancer, homogenized [OPG study]7.9299383
GSM549100patient 110, normal, homogenized [OPG study]9.5557192
GSM549107patient 135, normal, homogenized [OPG study]9.6902592
GSM549115patient 068, normal, homogenized [OPG study]9.8965993
GSM549116patient 072, normal, homogenized [OPG study]9.7699193
GSM549120patient 078, normal, homogenized [OPG study]9.7341693
GSM549131patient 030, cancer, homogenized [OPG study]9.7636793
GSM549118patient 074, normal, homogenized [OPG study]9.8456693
GSM549129patient 027, cancer, homogenized [OPG study]9.2773191
GSM549123patient 088, normal, homogenized [OPG study]9.291690
GSM549124patient 006, cancer, homogenized [OPG study]10.282496
GSM549126patient 015, cancer, homogenized [OPG study]9.7429893
GSM549128patient 025, cancer, homogenized [OPG study]10.171595
GSM549103patient 117, normal, homogenized [OPG study]9.2428491
GSM549117patient 073, normal, homogenized [OPG study]10.065993
GSM549138patient 041, cancer, homogenized [OPG study]9.6725593
GSM549141patient 045, cancer, homogenized [OPG study]9.6881692
GSM549130patient 028, cancer, homogenized [OPG study]9.8688194
GSM549101patient 111, normal, homogenized [OPG study]9.3798291
GSM549105patient 128, normal, homogenized [OPG study]9.3156591
GSM549106patient 134, normal, homogenized [OPG study]7.9992880
GSM549112patient 048, normal, homogenized [OPG study]9.5355491
GSM549125patient 011, cancer, homogenized [OPG study]9.9353394
GSM549127patient 024, cancer, homogenized [OPG study]9.0292989
GSM549135patient 035, cancer, homogenized [OPG study]9.8199693